Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanchang Tanzhen Biotechnology is a specialized biotechnology company focused on the development and application of high-throughput single-cell sequencing and spatial multi-omics technologies. The company provides integrated solutions for clinical research and drug discovery, including spatial transcriptomics, single-cell RNA sequencing, and sophisticated bioinformatics analysis. Their platform is designed to map cellular heterogeneity and the tumor microenvironment with high resolution, facilitating the identification of novel biomarkers and therapeutic targets. Tanzhen Bio serves a diverse clientele including academic institutions, hospitals, and pharmaceutical companies, supporting precision medicine initiatives. The company is positioned as a key player in the Chinese genomics services market, particularly in the rapidly evolving field of spatial biology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanchang Tanzhen Biotechnology.